ArticleInternal medicine (Tokyo, Japan)2017

Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience.

Takayuki Katsuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.